ES2178675T3 - Agente estimulante del tejido duro. - Google Patents

Agente estimulante del tejido duro.

Info

Publication number
ES2178675T3
ES2178675T3 ES95926565T ES95926565T ES2178675T3 ES 2178675 T3 ES2178675 T3 ES 2178675T3 ES 95926565 T ES95926565 T ES 95926565T ES 95926565 T ES95926565 T ES 95926565T ES 2178675 T3 ES2178675 T3 ES 2178675T3
Authority
ES
Spain
Prior art keywords
pct
hard tissue
sec
stimulating agent
date
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95926565T
Other languages
English (en)
Inventor
Hans-Arne Hansson
Gunilla Johansson-Ruden
Olle Larm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medicarb AB
Original Assignee
Medicarb AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medicarb AB filed Critical Medicarb AB
Application granted granted Critical
Publication of ES2178675T3 publication Critical patent/ES2178675T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

USO DE QUITOSANO Y UN POLISACARIDO INMOVILIZADO AL MISMO SELECCIONADO A PARTIR DE HEPARINA, SULFATO DE HEPARANO, CONDROITINSULFATOS Y SULFATO DE DEXTRANO PARA LA FABRICACION DE UN AGENTE CAPAZ DE PROPORCIONAR LA REGENERACION ESTIMULADA DE TEJIDO DURO; PROCESO PARA ESTIMULAR LA REGENERACION DE TEJIDO DURO EN CONEXION CON LA LLAMADA OSTEOINTEGRACION; E IMPLANTE PENSADO PARA LA INTEGRACION DE TEJIDO DURO, ESPECIALMENTE TEJIDO OSEO.
ES95926565T 1994-07-19 1995-07-13 Agente estimulante del tejido duro. Expired - Lifetime ES2178675T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9402528A SE9402528D0 (sv) 1994-07-19 1994-07-19 Hårdvävnadsstimulerande med el

Publications (1)

Publication Number Publication Date
ES2178675T3 true ES2178675T3 (es) 2003-01-01

Family

ID=20394768

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95926565T Expired - Lifetime ES2178675T3 (es) 1994-07-19 1995-07-13 Agente estimulante del tejido duro.

Country Status (22)

Country Link
US (1) US5894070A (es)
EP (1) EP0771206B1 (es)
JP (1) JP3492377B2 (es)
KR (1) KR100395724B1 (es)
CN (1) CN1081923C (es)
AT (1) ATE219678T1 (es)
BR (1) BR9508322A (es)
CA (1) CA2194462C (es)
CZ (1) CZ289981B6 (es)
DE (1) DE69527203T2 (es)
DK (1) DK0771206T3 (es)
ES (1) ES2178675T3 (es)
FI (1) FI970202A0 (es)
HU (1) HU220770B1 (es)
IS (1) IS1793B (es)
MX (1) MX9700443A (es)
NO (1) NO310223B1 (es)
NZ (1) NZ290219A (es)
PL (1) PL181764B1 (es)
RU (1) RU2153877C2 (es)
SE (1) SE9402528D0 (es)
WO (1) WO1996002259A1 (es)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9402528D0 (sv) * 1994-07-19 1994-07-19 Astra Ab Hårdvävnadsstimulerande med el
KR100237738B1 (ko) * 1997-04-26 2000-01-15 이용찬 생채 매식용 의료기구 임플란트의 기능 향상방법
DE19724869C2 (de) * 1997-06-12 1999-05-12 Henkel Kgaa Verwendung von Citosanderivaten zur Oberflächenbeschichtung
EP0899247B1 (en) * 1997-08-28 2002-11-06 Ngk Spark Plug Co., Ltd Calcium phosphate cement and calcium phosphate cement composition
JP4215884B2 (ja) * 1998-03-23 2009-01-28 日本特殊陶業株式会社 リン酸カルシウムセメント及びリン酸カルシウムセメント組成物
US20030147860A1 (en) * 2002-02-07 2003-08-07 Marchosky J. Alexander Compositions and methods for forming and strengthening bone
CA2335058A1 (en) 1998-06-22 1999-12-29 Danforth Joslyn Method, implant and delivery system for enhancing blood flow in tissue
WO2000027889A1 (fr) * 1998-11-10 2000-05-18 Netech Inc. Derive fonctionnel du chitosane
FR2791262B1 (fr) * 1999-03-22 2001-09-28 Virbac Sa Compositions a base de chondroitine et de chitosan pour la protection, le traitement ou le remplacement des tissus conjonctifs
WO2001000792A1 (en) 1999-06-29 2001-01-04 Marchosky J Alexander Compositions and methods for forming and strengthening bone
GB9920393D0 (en) * 1999-08-27 1999-11-03 Medix Scient Uk Limited Plant extract mixtures and their uses
FI19991852A (fi) 1999-09-01 2001-03-01 Yli Urpo Antti Uusi monikerroksinen materiaali, joka käsittää vaikuttavan ainesosan, ja sen valmistus
EP1229940B1 (en) * 1999-11-15 2014-05-14 Piramal Healthcare (Canada) Limited Temperature-controlled and ph-dependant self-gelling biopolymeric aqueous solution
EP1255576B1 (en) * 1999-12-09 2003-08-20 Biosyntech Canada Inc. Mineral-polymer hybrid composition
US20030158302A1 (en) * 1999-12-09 2003-08-21 Cyric Chaput Mineral-polymer hybrid composition
KR100880622B1 (ko) * 2000-06-29 2009-01-30 바이오신텍 캐나다 인코포레이티드 연골 및 다른 조직의 복구 및 재생용 조성물 및 방법
ES2169681B1 (es) * 2000-08-10 2003-10-01 Osfarma S L Metodo de produccion de filmes de quitosan con una alta capacidad de adherencia celular, producto obrenido y aplicaciones.
WO2002040070A2 (en) * 2000-11-15 2002-05-23 Bio Syntech Canada Inc. Method for restoring a damaged or degenerated intervertebral disc
JP5614913B2 (ja) * 2002-07-16 2014-10-29 ピラマル ヘルスケア （カナダ） リミテッド 生細胞又は生物学的活性因子を封入し送達するための、細胞適合性、注射可能、かつ自己ゲル化性のキトサン溶液の組成物
US20040054414A1 (en) 2002-09-18 2004-03-18 Trieu Hai H. Collagen-based materials and methods for augmenting intervertebral discs
FR2844717B1 (fr) * 2002-09-23 2006-07-07 Richard Cancel Plaque de renfort comprenant notamment du chitosane
CN100394989C (zh) * 2002-11-15 2008-06-18 华沙整形外科股份有限公司 包含微粒状基于胶原材料的组合物的制药应用和包含所述组合物的滑膜关节
US20040186471A1 (en) * 2002-12-07 2004-09-23 Sdgi Holdings, Inc. Method and apparatus for intervertebral disc expansion
DE10338110A1 (de) * 2003-08-15 2005-03-10 Biomet Deutschland Gmbh Mit Chitosan beschichteter metallischer Gegenstand sowie Verfahren zu dessen Herstellung
US20070231788A1 (en) * 2003-12-31 2007-10-04 Keyvan Behnam Method for In Vitro Assay of Demineralized Bone Matrix
EP1701729B1 (en) 2003-12-31 2018-05-02 Warsaw Orthopedic, Inc. Improved bone matrix compositions and methods
US8734525B2 (en) * 2003-12-31 2014-05-27 Warsaw Orthopedic, Inc. Osteoinductive demineralized cancellous bone
FR2866571B1 (fr) * 2004-02-20 2007-09-21 Philippe Zanchetta Utilisation d'un melange de polysaccharides specifiques denomme par l'inventeur ezbone, comprenant de l'acide hyaluronique, de la chondroitine 6 sulfate, du dermatane sulfate et de l'heparine en cicatrisation osseuse.
SG152297A1 (en) * 2004-05-07 2009-05-29 Univ Queensland Au Composition for stimulating bone growth and differentiation and method for isolating same
AU2005239977B2 (en) * 2004-05-07 2010-11-11 The University Of Queensland Composition for stimulating bone growth and differentiation and method for isolating same
WO2006019357A1 (en) 2004-08-16 2006-02-23 Cellresearch Corporation Pte Ltd Isolation of stem/progenitor cells from amniotic membrane of umbilical cord.
JP2008527033A (ja) * 2005-01-19 2008-07-24 ボンオス・メディカル・アー・ベー 増殖因子組成物
CN103555655B (zh) 2005-10-21 2018-02-27 细胞研究私人有限公司 自脐带羊膜分离和培养干/祖细胞及其分化的细胞的应用
CN101365499A (zh) 2005-11-01 2009-02-11 骨骼技术股份有限公司 骨基质组合物和方法
EP1945712A4 (en) * 2005-11-04 2013-05-01 Piramal Healthcare Canada Ltd BINDING OF AQUEOUS POLYELECTROLYTE SOLUTIONS BY THERMALLY INDUCED CHANGES IN THE IONIZATION CONDITION
DE102006020035A1 (de) * 2006-04-26 2007-10-31 B. Braun Melsungen Ag Herstellung und Verwendung von Poly(hydroxyethylstärke)chitin- und Poly(Carboxymethylstärke)chitin-Verbindungen
US8118779B2 (en) * 2006-06-30 2012-02-21 Warsaw Orthopedic, Inc. Collagen delivery device
US8399619B2 (en) * 2006-06-30 2013-03-19 Warsaw Orthopedic, Inc. Injectable collagen material
EP1977739A1 (en) * 2007-04-03 2008-10-08 Bioiberica, S.A. Nanoparticulate composition of chitosan and chondroitin sulfate
CA2945295C (en) * 2007-06-15 2020-01-14 Warsaw Orthopedic, Inc. Method of treating tissue
CA2690457C (en) 2007-06-15 2018-02-20 Osteotech, Inc. Bone matrix compositions and methods
US9554920B2 (en) 2007-06-15 2017-01-31 Warsaw Orthopedic, Inc. Bone matrix compositions having nanoscale textured surfaces
US20110054408A1 (en) * 2007-07-10 2011-03-03 Guobao Wei Delivery systems, devices, tools, and methods of use
WO2009009684A1 (en) * 2007-07-10 2009-01-15 Osteotech, Inc. Delivery system
EP2211921B1 (en) 2007-10-19 2013-12-25 Warsaw Orthopedic, Inc. Demineralized bone matrix compositions and methods
GB2463474B (en) * 2008-09-11 2012-05-02 Agency Science Tech & Res Therapeutic bone growth and regeneration
WO2010093955A1 (en) 2009-02-12 2010-08-19 Osteotech,Inc. Segmented delivery system
WO2013110681A1 (en) 2012-01-27 2013-08-01 F. Hoffmann-La Roche Ag Chitosan covalently linked with small molecule integrin antagonist for targeted delivery
EP3003026B1 (en) * 2013-03-14 2019-07-17 Tricol Biomedical, Inc. Biocompatible and bioabsorbable derivatized chitosan compositions
CN105126165B (zh) * 2015-01-21 2017-12-08 中国人民解放军第三〇七医院 一种钛牙种植体材料及其制备方法与应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL163522B (nl) * 1970-07-20 1980-04-15 Montedison Spa Werkwijze om een katalysator te bereiden voor de polymerisatie van alkenen-1.
US5510418A (en) * 1988-11-21 1996-04-23 Collagen Corporation Glycosaminoglycan-synthetic polymer conjugates
BR9207010A (pt) * 1991-12-31 1995-12-05 Minnesota Mining & Mfg Composição adesiva e processo de aderência de um material restaurador a um substrato
US5256447A (en) * 1991-12-31 1993-10-26 Minnesota Mining And Manufacturing Company Adhesive composition and method
SE9402528D0 (sv) * 1994-07-19 1994-07-19 Astra Ab Hårdvävnadsstimulerande med el

Also Published As

Publication number Publication date
SE9402528D0 (sv) 1994-07-19
IS4409A (is) 1997-01-06
PL181764B1 (pl) 2001-09-28
JPH10502664A (ja) 1998-03-10
EP0771206B1 (en) 2002-06-26
US5894070A (en) 1999-04-13
CZ289981B6 (cs) 2002-05-15
DK0771206T3 (da) 2002-08-19
CN1081923C (zh) 2002-04-03
NO310223B1 (no) 2001-06-11
ATE219678T1 (de) 2002-07-15
WO1996002259A1 (en) 1996-02-01
HUT77607A (hu) 1998-06-29
CN1157568A (zh) 1997-08-20
JP3492377B2 (ja) 2004-02-03
NO970215L (no) 1997-01-17
HU220770B1 (hu) 2002-05-28
DE69527203T2 (de) 2003-01-09
BR9508322A (pt) 1998-01-06
KR970704459A (ko) 1997-09-06
CZ14097A3 (en) 1997-07-16
CA2194462C (en) 2007-07-10
FI970202A (fi) 1997-01-17
NO970215D0 (no) 1997-01-17
CA2194462A1 (en) 1996-02-01
HU9700160D0 (en) 1997-03-28
EP0771206A1 (en) 1997-05-07
PL318326A1 (en) 1997-06-09
MX9700443A (es) 1997-04-30
AU696183B2 (en) 1998-09-03
RU2153877C2 (ru) 2000-08-10
IS1793B (is) 2001-12-12
DE69527203D1 (de) 2002-08-01
NZ290219A (en) 1998-06-26
AU3089595A (en) 1996-02-16
FI970202A0 (fi) 1997-01-17
KR100395724B1 (ko) 2004-02-18

Similar Documents

Publication Publication Date Title
ES2178675T3 (es) Agente estimulante del tejido duro.
RU97102352A (ru) Агент, стимулирующий твердую ткань
CA2194976A1 (en) Wound healing agent
SE9003206D0 (sv) Saett foer ytbehandling av implantat av titan eller titanlegering
KR100381207B1 (es)
NO303425B1 (no) FremgangsmÕte for behandling av et kirurgisk metallimplantat
ATE305276T1 (de) Eingeschlagenes orthopädisches knochenstützimplantat
SE9404196D0 (sv) New antithrombotic formulation
NZ502610A (en) Use of lactobacillus for reduction of the fibrinogen level in blood
ATE211636T1 (de) Methode zum herstellen eines dentalproduktes
ES2180649T3 (es) Agente antiadherente.
EP1072273A4 (en) VASKULARISIERUNGSINHIBITOREN
MY140626A (en) Drug screening methods and method of treatment
RU2002109358A (ru) Способ подготовки сосудистого фторлон-лавсанового протеза
Tzifa et al. Cosmetic tracheostomy locket: an attempt to improve the aesthetic component of tracheostomy tubes
MX9504896A (es) Pericardio bovino tratado con glutaraldehido, como bioprotesis de pared toracoabdominal, tejido pulmonar y bronquial.
UA23896A (uk) Спосіб лікування зламів нижньої щелепи із сповільненою консолідацією
RU95116161A (ru) Способ лечения синдрома диссеминированного внутрисосудистого микротромбоза при тяжелой изолированной и сочетанной черепно-мозговой травме
RU2000103476A (ru) Способ лечения больных с нарушениями консолидации переломов длинных костей конечностей
UA32173A (uk) Спосіб лікування недорозвиненої середньої зони лицевого скелету